Average Co-Inventor Count = 7.46
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (7 from 410 patents)
2. Janssen Pharmaceutica Nv (4 from 2,076 patents)
3. Stichting Vumc (2 from 7 patents)
11 patents:
1. 12077592 - GPRC5D chimeric antigen receptors and cells expressing the same
2. 12065500 - Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics
3. 12012461 - Methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics
4. 11884722 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
5. 11685777 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
6. 11603405 - Anti-CD3 antibodies and uses thereof
7. 11466082 - Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof
8. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
9. 10562968 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof
10. 10072088 - Anti-BCMA antibodies and uses thereof
11. 9850310 - CD123 binding agents and uses thereof